摘要:
A computing system is configured to accept bid rules from merchants for the placement of ads for a plurality of products. The bid rules comprise a bid amount, a rule definition and a priority. The bid amount may be an absolute bid or it may be relative to base advertising rate. The rule definition comprises criteria for describing products to determine when the bid rule is applied to a product for sale. The priority indicates whether the bid rule applies to a particular product when the rule definition of more than one bid rule could be applied to a product. The computing system is also configured to generate a list of product offers based at least in part on the bids. The system may also generate reports for merchants.
摘要:
The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I) wherein n, R1, R2, R3, R4, R5, R6 and X have defined meanings.
摘要:
The present invention provides compounds of formula (I) and compounds of formula (VII-a) as well as pharmaceutical compositions comprising said compounds and their use as PARP inhibitors wherein n, R1, R2, R3, R4, R5, R6, R7, Re, Rd and X have defined meanings.
摘要:
High molecular weight coupled block copolymer composition comprising (a) a linear diblock copolymer (I) represented by the general formula (A-B), having a peak apparent molecular weight of from 200,000 to 300,000, (b) a linear di-armed block copolymer (II), represented by the general formula (A-B)2X, (c) a tri-armed block copolymer (III), represented by the formula (A-B)3X, (d) a more than tri-armed block copolymer (IV), represented by the formula (A-B)n>3X, (e) side polymeric structures (SPS) having a peak apparent molecular weight below the linear diblock copolymer (I), wherein A represents a block of predominantly poly(monovinyl aromatic hydrocarbon) and wherein the poly(monovinyl aromatic hydrocarbon) content is in the range of from 20 to 35 wt %; wherein B represents a block of predominantly poly(conjugated diene); wherein X is the residue of a trifunctional and/or tetrafunctional coupling agent; wherein the block copolymer composition has a weight average molecular weight Mw in the range of from 450,000 to 800,000, and wherein the relative amounts of block copolymers corresponds to: I is from 5 to 15 wt %; II and III together are from 70 to 90 wt %, wherein III is above 10 wt %; IV is below 10 wt % and SPS is less than 10 wt % respectively, relative to the weight of the total block copolymer composition, in which the respective components add up to 100%.
摘要:
The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I) wherein n, R1, R2, R3, R4, R5, R6 and X have defined meanings.
摘要:
The present invention concerns compounds of formula. In a preferable embodiment, X represents O; R1 represents C1-6alkyl; cycloC3-12alkyl or (cycloC3-12alkyl)C1-6alkyl, wherein one or more hydrogen atoms in a C1-6alkyl-moiety or in a cycloC3-12alkyl-moiety optionally may be replaced by C1-6alkyloxy, aryl, halo or thienyl; R2 represents hydrogen; halo; C1-6alkyl or amino; R3 and R4 each independently represent hydrogen or C1-6alkyl; or R2 and R3 may be taken together to form —R2—R3—, which represents a bivalent radical of formula —Z4—CH2—CH2—CH2— or —Z4—CH2—CH2— with Z4 being O or NR11 wherein R11 is C1-6alkyl; and wherein each bivalent radical is optionally substituted with C1-6alkyl; or R3 and R4 may be taken together to form a bivalent radical of formula —CH2—CH2—CH2—CH2—; R5 represents hydrogen; Y represents O; and aryl represents phenyl optionally substituted with halo. The invention also relates to the use of a compound according to the invention as a medicament and in the manufacture of a medicament for treating or preventing glutamate-induced diseases of the central nervous system, as well as formulations comprising such a compound and processes for preparing such a compound.
摘要:
The present invention is concerned with compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein R1 is hydrogen, hydroxy, C1-6alkyl or aryl; R2 is hydrogen; optionally substituted C1-12alkyl; C3-7cycloalkyl; C2-8alkenyl, optionally substituted pyrrolidinyl or aryl; R3 is hydrogen, optionally substituted C1-6alkyl or aryl; Het is an optionally substituted unsaturated heterocycle selected from imidazolyl, triazolyl, tetrazolyl and pyridinyl; is an optionally substituted unsaturated mono- or bicyclic heterocycle; and aryl is optionally substituted phenyl. The present invention also relates to processes for their preparation and compositions comprising said new compounds, as well as their use as a medicine.
摘要翻译:本发明涉及配制N-氧化物的化合物,其药学上可接受的加成盐和立体化学异构形式,其中R 1是氢,羟基,C 1-6烷基或芳基; R2是氢; 任选取代的C 1-12烷基; C 3-7环烷基; C 2-8烯基,任选取代的吡咯烷基或芳基; R3是氢,任选取代的C 1-6烷基或芳基; Het是选自咪唑基,三唑基,四唑基和吡啶基的任选取代的不饱和杂环;是任选取代的不饱和单环或双环杂环; 并且芳基是任选取代的苯基。 本发明还涉及其制备方法和包含所述新化合物的组合物,以及它们作为药物的用途。
摘要:
A reactor arrangement and process for indirectly contacting a reactant stream with a heat exchange stream uses an arrangement of heat exchange plates to control temperature conditions by varying the heat transfer factor in different portions of a continuous channel defined by the heat exchange plates. The reactor arrangement and process of this invention may be used to operate a reactor under isothermal or other controlled temperature conditions. The variation in the heat transfer factor within a single heat exchange section is highly useful in maintaining a desired temperature profile in an arrangement having a cross-flow of heat exchange medium relative to reactants. The corrugations arrangement eliminates or minimizes the typical step-wise approach to isothermal conditions.
摘要:
An injection head including an annular distribution cavity for distributing a propellant upstream from an injection plate supporting injectors. The cavity includes a multiply-perforated distribution grid distributing the propellant, which grid is coaxial with the distribution cavity and of a concave shape that projects into the distribution cavity, the grid being fastened to a dome of the cavity.